Skip to main content
UKPMC Funders Author Manuscripts logoLink to UKPMC Funders Author Manuscripts
. Author manuscript; available in PMC: 2026 Jun 3.
Published in final edited form as: J Mol Cell Cardiol. 2025 Jul 24;206:127–140. doi: 10.1016/j.yjmcc.2025.07.014

Compromised repolarization reserve in a murine model of catecholaminergic polymorphic ventricular tachycardia caused by RyR2-R420Q mutation

Spyros Zissimopoulos a, Pavel Kirilenko b, Aitana Braza-Boïls c,d, Esther Zorio c,d,e,f, Yueyi Wang g,1, Ana Maria Gomez g, Mark B Cannell h, Branko Latinkic b, Ewan D Fowler b,*
PMCID: PMC7619069  EMSID: EMS213698  PMID: 40714045

Abstract

Background

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a malignant inherited heart disease characterised by stress-induced arrhythmias that are thought to be caused by delayed after-depolarizations resulting from abnormal Ca2+ cycling. Some patients exhibit unusually large ECG U-waves that could be associated with altered ventricular repolarization, but the possible link with dysfunctional RyR2 is unclear. We investigated whether increased Ca2+ leak during systole disrupts repolarization in a transgenic mouse model of CPVT.

Methods

Electrocardiograms were recorded in patients with RyR2-R420Q CPVT mutation (R420Q). Experiments were performed on control and R420Q knock-in mouse hearts and ventricular myocytes.

Results

R420Q patients had larger resting U-waves than family member controls. R420Q mouse hearts exhibited greater prolongation of monophasic APs following pauses in pacing and during beta-adrenergic stimulation. Ventricular ectopic beats during repolarization were more prevalent in R420Q mouse hearts following pacing-pauses and during premature electrical stimulation. Early afterdepolarizations (EADs) occurred in isolated R420Q myocytes during beta-adrenergic stimulation and coincided with increased Ca2+ leak during the Ca2+ transient decay, in the form of late Ca2+ sparks (LCS). AP voltage clamp electrophysiology experiments, analysis of LCS recovery, and computer simulations of hyperactive RyR2 supported a mechanism involving increased RyR2 sensitivity and/or reduced refractoriness that increased LCS frequency and inward sodium/calcium exchange current, resulting in AP prolongation and EADs.

Conclusions

Ca2+-mediated AP lengthening and EADs may contribute to proarrhythmic behaviour in CPVT caused by gain-of-function R420Q mutation. Loss of repolarization reserve is not specifically targeted by CPVT therapies but could be an opportunity for therapeutic intervention.

Keywords: CPVT, Arrhythmias, Early afterdepolarizations, Calcium sparks, Repolarization reserve

1. Introduction

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a malignant inherited cardiac disease characterised by ventricular tachyarrhythmias that carries increased risk of sudden death brought on by exercise or emotional stress. [1,2] Mutations in the ryanodine receptor (RyR2) Ca2+ release channel have been identified in more than 50 % of CPVT patients and carry an autosomal dominant inheritance pattern. [3] CPVT is normally associated with hyperactive (“leaky”) RyR2, [4] causing increased Ca2+ spark rate and Ca2+ wave initiation in cardiac myocytes. Delayed afterdepolarizations (DADs) caused by diastolic Ca2+ waves are thought to be the underlying mechanism for arrhythmias and ventricular tachycardia in both preclinical models [57] and CPVT patients. [8] Current treatments for CPVT, such as beta-blockers and/or flecainide, are aimed at reducing DADs but do not provide complete protection against adverse cardiac events in all patients, [9] so a better understanding of the cellular mechanisms is needed.

Bidirectional ventricular tachycardia reportedly arose from late coupled extrasystolic beats in both patients and transgenic mice carrying the RyR2-R4496C+/− CPVT mutation, [10] which would be consistent with a diastolic DAD-mediated mechanism. However, other ECG abnormalities have been reported in some CPVT patients, such as biphasic or notched T-wave morphology [11,12] and increased U-wave amplitude. [13,14] The cause of U-waves in humans is not fully understood and there may be overlap between mechanisms in different diseases. [15] U-waves are commonly associated with dysfunction of membrane ion channels and prolonged repolarization in conditions such as the long QT syndrome, [16] but these ionic currents are not thought to be altered in CPVT. Transmural repolarization gradients could alter U-wave morphology, and quantitative differences in repolarization gradients in mice versus larger mammals might explain why mice do not normally exhibit U-waves. [17] DADs were also shown to cause U-waves in canine ventricular wedge preparations. [18] Diastolic Ca2+ sparks and Ca2+ waves are normally suppressed during an apparent refractory period following a Ca2+ transient, [19,20] so it is unclear whether they can explain short-coupled abnormal T- and U-waves.

It was previously reported that patients with RyR2-R420Q+/− (R420Q) mutation exhibited augmented U-waves and that isolated myocytes from R420Q knock-in mice had increased spontaneous dia-stolic Ca2+ release. [13] In this study, we sought to establish how dys-regulation of intracellular Ca2+ handling caused by this mutation impacts electrophysiology at the cellular and organ level, particularly whether it could contribute to abnormal repolarization. We investigated the inducibility of arrhythmias in intact perfused hearts and performed patch clamp electrophysiology and confocal Ca2+ imaging in isolated ventricular myocytes from R420Q mice. Mouse is currently the only mammalian model of human CPVT caused by gain-of-function RyR2, [5] but the mouse heart differs from human in some key areas, such as reliance on repolarizing K+ currents, action potential duration (APD) and morphology and consequently impact of Na+/Ca2+ exchange current (INCX) on APD. Mouse ventricular myocytes share most of the Ca2+ handling mechanisms with humans and the R420Q mouse model replicates some of the electrophysiological features of the human disease, including a similar rate of ventricular tachycardia under basal conditions (compared to wildtype controls), but a greater incidence of arrhythmias in response to pharmacological or emotional stress. [21,22] Transgenic mice have also been used to study both DAD and early afterdepolarization (EAD) mechanisms, such as in Andersen-Tawil syndrome. [23] Our results indicate that RyR2 hypersensitivity increases Ca2+ leak during systole that contributes to AP lengthening and susceptibility to arrhythmias arising during ventricular repolarization in CPVT.

2. Methods

Detailed methods are available in the online Supplementary Materials. Experiments were conducted with local ethical approval in accordance with UK Home Office, French Ministry of Sciences (APAFIS#1297–2,015,072,114,403,692) and European Parliament Directive 2010/63/EU guidelines on the use of animals in research. Clinical evaluation of CPVT patients was conducted after signing informed consent in accordance with the Declaration of Helsinki and with the approval of the local Institutional Ethics Committee at the in Hospital Universitario y Politécnico La Fe de Valencia, Spain (#2018/0365). Detailed clinical characterisation of CPVT-causing RyR2 mutations used in this study were described in previous reports. [13,21,24]

3. Results

Table 1 summarises resting ECG parameters in patients with the CPVT-causing R420Q mutation in the N-terminus of RyR2 (RyR2-R420Q) and genotype negative family members. QT and QTc intervals were not different between groups at rest. Fig. 1A shows an exemplar resting ECG recording from an R420Q patient with prominent U-waves that occurred immediately after, and merged with, the preceding T-wave, forming a TU complex. To analyse the U-wave component, digitized recordings of the TU complex were fitted with the sum of a decaying exponential and a Gaussian curve (Fig. 1B), following the method of Reilly et al. [25] The U-wave integral calculated using this method was greater in R420Q patients compared to controls (Fig. 1C). Large U-waves have also been reported with RyR2 mutations in other regions of the channel, such as the helical domain (RyR2-C2277R) (Fig. S1), [24] N-terminus domain (RyR2-R169Q), [26] bridging solenoid B (RyR2-P2328S), [11] and exon-3 deletion, [27] indicating that U-waves are not unique to the R420Q mutation examined here.

Table 1.

Summary ECG parameters of human RyR2-R420Q patients and genotype-negative family member controls. QTc was corrected using Bazzett’s formula (QTc=QT/√RR) QaU, interval from start of the QRS complex to the apex of the U-wave. NS, not significant.

Control (N = 5) R420Q (N = 4)
Mean SEM Mean SEM P value
RR interval 0.89 ± 0.10 1.00 ± 0.07 NS (0.42)
QT (s) 0.39 ± 0.02 0.41 ± 0.03 NS (0.59)
QTc (s) 0.37 ± 0.05 0.41 ± 0.02 NS (0.73)
QaU interval (s) 0.49 ± 0.02 0.55 ± 0.03 NS (0.058)
U integral (ms.mV) 1.79 ± 0.60 8.44 ± 2.86 2.80 × 10–2

Fig. 1. Increased ECG U-waves in RyR2-R420Q patients.

Fig. 1

A Resting ECG recordings from an RyR2-R420Q patient (right panel) and a genotype-negative family member control (left panel). Arrow indicates the large U-waves that occurred immediately following, and merging with, the preceding T-wave. B Resting ECG in a different R420Q patient. Method for analysing the T-wave and U-wave (shaded area) components of the TU complex by fitting the sum of a decaying exponential and Gaussian curve (green line), to digitized ECG recordings, as described in [25]. C The U-wave integral was greater in R420Q patients. Statistical analysis was conducted on the mean U-wave integral for each patient or control (open circles and bars) from the average of 1–3 cycles (individual cycle values from each patient or control are shown with different symbols beside the histogram bars). (C) unpaired t-test. N = 5 genotype negative family member controls and N = 4 R420Q patients. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

3.1. Prolonged action potential repolarization in R420Q hearts

We used a transgenic mouse model with a heterozygous RyR2-R420Q mutation (R420Q) to explore the impact of this mutation on repolarization. Left ventricular epicardial monophasic action potentials (MAP) and pseudo-ECGs were recorded in isolated WT and R420Q mouse hearts. Fig. 2A shows an exemplar recording from an R420Q heart in which a ventricular ectopic beat (VEB) occurred during AP repolarization of the first sinus beat following a pause in 10 Hz pacing. This is seen more clearly on an expanded timescale in Fig. 2B, where it is overlaid with a normal beat to emphasise that the ectopic beat occurred near the peak of the corresponding ECG T-wave. VEB occurred during AP repolarization following a pause in 3/9 R420Q hearts (Fig. 2C), but not in any WT hearts (N = 10). The mean pause interval between final 10 Hz stimulus and first sinus beat was 364 ± 4 ms in WT and 408 ± 35 ms in R420Q hearts, which was not significantly different (P = 0.44; unpaired t-test). The mean cycle length during sinus rhythm following this stimulation protocol was 245 ± 23 ms in WT and 346 ± 51 ms which was also not significantly different (P = 0.074; Mann-Whitney test). In some hearts, subthreshold diastolic depolarizations in the MAP were observed during the pause that might indicate delayed afterdepolarizations (Fig. S2), however these did not initiate ectopic beats or VT/VF in any R420Q hearts under these experimental conditions.

Fig. 2. Pause-dependent ventricular ectopic beats (VEB) and AP lengthening in transgenic R420Q mouse hearts.

Fig. 2

A Monophasic action potential (MAP) and pseudo-ECG recording (pECG) measured simultaneously in an R420Q heart. When electrical pacing was turned off (top panel) there was a pause before sinus rhythm resumed, evident by the presence of P-waves (P). A VEB occurred during repolarization of the first sinus beat after the pause B Grey lines show the VEB in (A) overlaid with a different beat from the same heart that repolarizes normally on an expanded time scale (black lines). The VEB coincides with a premature ventricular complex on the ECG (double arrow), confirming this was not an artefact of MAP recording. C Pause-induced VEB occurred in 3/9 R420Q and 0/10 WT hearts. D Exemplar sinus rhythm MAP from a WT and R420Q heart. E Sinus rhythm MAPD90 was not different between WT and R420Q hearts. F Exemplar recording from an R420Q heart during and after burst pacing. G Exemplar MAP recordings from a WT and R420Q heart showing the first (thick line) and fifth (thin line) sinus beat following burst pacing. H MAPD90 was longer during the first post-pause beat in R420Q compared to WT hearts and also I when normalized to the steady state MAPD90 in the same heart. N = 10 WT and 9 R420Q hearts. (E,H,I) Unpaired t-test.

We next investigated whether AP prolongation could account for triggered activity during repolarization. The MAP duration at 90 % repolarization (MAPD90) and average cycle length (WT, 302 ± 20 ms; R420Q, 327 ± 31 ms; P = 0.56 unpaired t-test) were not different between WT and R420Q hearts during steady sinus rhythm (Fig. 2D,E). It was reported that pauses in rhythm caused a transient increase in U-wave amplitude in R420Q patients, [13] and similarly we found increased post-extrasystolic U-waves in an RyR2-C2277R patient (Supp. Fig. 1B), so we examined whether pauses in rhythm could induce AP lengthening in R420Q mouse hearts. A pacing protocol with a brief burst of 10 stimuli at short cycle length (28–60 ms) was used to elicit maximal heart rate (WT, 12.6 ± 0.4 Hz; R420Q, 12.5 ± 0.9 Hz; P = 0.92 unpaired t-test) then pacing was switched off (Fig. 2F). Fig. 2G shows exemplar MAP recordings during the first and fifth sinus beat in a WT and R420Q heart following pacing. The MAPD90 of the first sinus beat was longer in R420Q compared to WT hearts (Fig. 2H) including when post-pause MAPD90 values were normalized by the steady state MAPD90 in each heart (Fig. 2I).

3.2. Beta-adrenergic activation increases susceptibility to premature stimulation

When hearts were exposed to 100 nmol/L isoproterenol (ISO) the sinus cycle length shortened similarly in both WT and R420Q hearts (WT, 212 ± 31 ms; R420Q, 260 ± 40 ms; P = 0.43, unpaired t-test) and differential effects on repolarization between WT and R420Q hearts emerged. As might be expected, ISO shortened MAPD90 and slightly increased phase 2 of the AP in WT, but in R420Q hearts the increase in phase 2 became larger with almost no effect on MAPD90 (Fig. 3A,B). The change in phase 2 resulted in the MAPD at 30 % repolarization increasing in R420Q hearts but not in WT hearts (Fig. 3C). These data are consistent with reduced repolarization reserve in R420Q hearts, caused by imbalance between inward and outward currents, [28] which could increase vulnerability to extrasystoles. [29] We therefore investigated whether R420Q hearts were more susceptible to arrhythmias triggered by premature electrical stimulation (S1S2 protocol) (Fig. 3D). Premature S2 stimuli induced runs of triggered activity in 3/8 R420Q hearts in normal Tyrode’s solution (TYR), and in 6/8 hearts in the presence of ISO (Fig. 3E), whereas this did not occur in any WT hearts (Fig. 3E). Optical mapping was used in some additional experiments to monitor membrane potential changes in the mouse left ventricle epicardium during S1S2 stimulation. Fig. S3 shows that premature S2 stimulation delivered during repolarization in an R420Q heart prevented repolarization in tissue nearest the electrode (without eliciting a full AP) but that this depolarized region appeared to trigger activity in the surrounding area resulting in brief tachycardia. We observed that premature ectopic activity was also associated with an increase in U-wave amplitude following premature beats in an R420Q patient (Fig. S4).

Fig. 3. Altered repolarization in response to isoproterenol and premature stimulation in R420Q mouse hearts.

Fig. 3

A Exemplar MAP recordings from a WT and R420Q heart in control conditions (thick lines) and during stimulation with isoproterenol (100 nmol/L; ISO) (thin lines). In these examples, the WT MAPD at 90 % repolarization (MAPD90) was 98.4 ms in TYR and 66.0 ms in ISO, and the R420Q MAPD90 was 77.8 ms in TYR and 70.4 ms in ISO. B ISO shortened mean MAPD90 in WT but not R420Q hearts. C Conversely, ISO increased MAPD at 30 % repolarization in R420Q but not WT hearts. D S1S2 protocol involving progressively shorter S2 intervals (top) imposed at the end of steady pacing at 10 Hz. Exemplar recordings from a WT and R420Q heart in ISO when the final stimulus is at the normal 100 ms S1 cycle length (black lines) and at a shorter S2 interval of 80 ms (magenta lines). In the WT heart the shorter S2 elicits a single AP, whereas in the R420Q heart the same S2 pulse triggers EAD-like behaviour. Only a single S2 recording is shown for clarity but all hearts were subjected to all S2 intervals. E Percentage of hearts that developed arrhythmias in response to premature S2 electrical stimuli (PES) in control and ISO solutions (N = 10 WT and N = 8 R420Q hearts). (B,C) Paired t-test. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

3.3. Early afterdepolarizations in R420Q ventricular myocytes

The APD90 of single ventricular myocytes isolated from R420Q hearts was longer than WT cells during steady pacing at 1 Hz at 22 °C, as illustrated in Fig. 4A and summarized in Fig. 4B. In some R420Q cells, application of ISO (100 nmol/L) produced spontaneous EADs during 1 Hz pacing. To quantify the prevalence of EADs we used a pacing-pause protocol (illustrated in Fig. 4C). Few WT cells developed EADs following the pause in either TYR or ISO, whereas ~50 % of R420Q cells exhibited EADs following the pause in ISO (Fig. 4D). These experiments were repeated at a physiological temperature (35 °C) and similar results were found (Fig. S5). The Ca2+ current plays a role in EAD genesis, [30] however ICa density was similar in R420Q and WT cells (Fig. S6 and [22]) suggesting that ICa was not responsible for the difference in EADs. Increased Ca2+ leak during systole, in the form of ‘late Ca2+ sparks’ (LCS), can impair repolarization reserve in heart failure, resulting in AP lengthening and EADs by increasing inward NCX current. [31] LCS are Ca2+ sparks that occur during the Ca2+ transient decline after the initial AP-evoked Ca2+ release, [32] however their role in other diseases, including CPVT, remains unknown. Exemplar confocal Ca2+ line scan recordings of EADs during steady 1 Hz pacing (Fig. 4E) and following the pause (Fig. 4F) showed large numbers of LCS occurring in R420Q cells stimulated with ISO. In the latter case, Vm was initially in a quasi-stable state coinciding with dyssynchronous Ca2+ release, which eventually became more coordinated and in-phase with Vm leading to full repolarization. [33]

Fig. 4. Increased prevalence of EADs and APD lengthening in isolated R420Q mouse ventricular myocytes.

Fig. 4

A Exemplar APs recorded in isolated WT and R420Q ventricular myocytes at 22 °C using whole-cell patch clamp. B APD90 was longer in R420Q myocytes during pacing at 1 Hz in normal Tyrode’s solution. C Exemplar WT and R420Q APs during a pace (1 Hz) pause (5 s) protocol (top panel) in the presence of ISO. Some R420Q cells developed EADs during steady pacing, and especially in the beat following the pause. D Proportion of WT and R420Q cells that developed EADs during a pacing-pause protocol in normal Tyrode’s and during ISO stimulation. E Exemplar confocal Ca2+ line scan recording of an EAD during steady pacing and F following the pace-pause protocol illustrated in (C) in an R420Q myocyte during ISO stimulation. Large numbers of spontaneous late Ca2+ sparks are visible coinciding with delayed recovery of the cellular average Ca2+ transient (green line) and membrane potential (magenta) shown normalized as an overlay. Note the different time scales in panels E & F. (B) n/N (cells/hearts) = 19/3 WT and 22/5 R420Q. (D) n/N (cells/hearts) as indicated below bars. (B) Unpaired t-test. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

3.4. Increased frequency of late Ca2+ sparks in R420Q myocytes

Fig. 5A shows exemplar confocal Ca2+ line scan recordings of Ca2+ transients in a WT and R420Q myocyte in normal Tyrode’s solution. A small number of LCS occurred during the Ca2+ transient decay in WT, but were more frequent in R420Q cells, as can be seen more easily after high-pass image processing and automated LCS detection (white boxes, right panels). The increased LCS frequency in R420Q cells (Fig. 5B) was associated with a longer Ca2+ transient duration compared to WT cells (Fig. 5C). LCS can be promoted by impaired early Ca2+ release and increased SR load, [31,32,34] but the Ca2+ transient amplitude and synchrony of electrically evoked Ca2+ release was not different in R420Q cells (Fig. 5D and Fig. 5E, respectively). In addition, immuno-cytochemistry revealed that the transverse-tubule network was not disrupted in R420Q cells meaning that orphaning of RyR2 clusters was not involved, [35] as there was similar regularity and colocalization between RyR2 and the sarcolemma marker caveolin-3 (Fig. S7). SR Ca2+ content was significantly reduced in R420Q compared to WT cells in TYR and there was a trend for a reduction in ISO (Fig. S8), assessed by integration of the NCX current after rapid application of caffeine under voltage clamp, [36] consistent with a previous report. [22] Reduced SR Ca2+ load would normally be expected to reduce the probability of Ca2+ sparks occurring. [37]

Fig. 5. Increased frequency of late Ca2+ sparks (LCS) in isolated R420Q mouse ventricular myocytes.

Fig. 5

A Exemplar confocal Ca2+ line scan recordings. LCS during the Ca2+ transient decay were detected by automated algorithm in high-pass filtered recordings (white boxes, right panels). Event marked * is a diastolic Ca2+ spark occurring after [Ca2+] has returned to within 10 % of the resting level. B LCS frequency and C the full-duration at half maximum (FDHM) of the Ca2+ transient were increased in R420Q cells. D Ca2+ transient amplitude and E electrically-evoked Ca2+ release synchrony were similar between groups. F Increased LCS frequency during isoproterenol (ISO) stimulation. G LCS frequency and H Ca2+ transient duration was greater in R420Q myocytes during ISO stimulation, whereas I Ca2+ transient amplitude and J Ca2+ release synchrony were not different. (B-E) n/N = 20/4 WT and 17/6 R420Q cells/hearts, (G-J) n/N = 21/4 WT and 18/5 R420Q cells/hearts. Data points represent the mean value from each cell. Nested unpaired t-test.

ISO (100 nmol/L) increased LCS frequency in WT cells from 10.4 ± 2.2 to 23.6 ± 6.7 LCS/s/100 μm, but dramatically increased LCS frequency in R420Q cells to 117.3 ± 12.6 LCS/s/100 μm compared to 51.6 ± 8.8 LCS/s/100 μm in Tyrode’s (Fig. 5F,G). This difference was underscored by the fact that whereas LCS were not detectable in ~30 % of WT cells during ISO stimulation, LCS were detected in all R420Q cells in ISO (P < 0.001 vs WT ISO; χ2 test).

We used dual Ca2+/Vm cardiac optical mapping in WT and R420Q hearts to establish whether the Ca2+ transient was also prolonged in intact hearts. External Ca2+ was increased to 1.8 mmol/L during these experiments, which was found to increase the basal heart rate to 6.1 ± 0.3 Hz in WT and 6.0 ± 0.4 in CPVT hearts before dye loading (P = 0.84 WT vs R420Q unpaired t-test; N = 4 WT and N = 3 R420Q hearts). The mean Ca2+ transient duration was indeed significantly prolonged in R420Q hearts during normal sinus rhythm during stimulation with 1 μmol/L ISO (Fig. S9).

3.5. Late Ca2+ sparks prolong action potential duration in R420Q myocytes

To establish whether differences in AP shape and/or duration caused the increase in LCS frequency or alternatively, were a result of the prolonged Ca2+ transient and increased LCS, we used the AP voltage clamp (AP clamp) technique with either a typical WT (control AP) or R420Q AP (CPVT AP) as the voltage command. Fig. 6A shows exemplar confocal Ca2+ line scans recorded under AP clamp following standardized SR Ca2+ loading by a series of square voltage steps to +10 mV. Overall, LCS frequency was greater in R420Q cells compared to WT cells when clamped with a control AP (Fig. 6B), but within each cell type LCS frequency did not change depending on which AP waveform was used (Fig. 6C).

Fig. 6. Time and voltage dependence of LCS in WT and R420Q mouse ventricular myocytes.

Fig. 6

The WT and R420Q exemplar APs from Fig. 4A were used as canonical Control and CPVT command waveforms for AP voltage clamp experiments, respectively. A Exemplar confocal Ca2+ line scan recordings in a WT (top panels) and R420Q cell (bottom panels) under voltage clamp with a Control (left panels) or CPVT AP (right panels) following standardized Ca2+ loading with a sequence of square pulses to +10 mV (see Supplementary Materials). B LCS frequency was greater in R420Q compared to WT cells under voltage clamp with a Control AP. C The frequency of LCS was not dependent on the particular AP waveform in either WT or R420Q cells (shown as the difference in LCS frequency clamped with a CPVT AP minus frequency with a Control AP). D (from top to bottom) Exemplar Ca2+ line scan recording, detected Ca2+ sparks, membrane potential, cellular average Ca2+ transient, and histogram of detected Ca2+ sparks in an R420Q cell under current clamp. Ca2+ spark events are marked by short lines on Vm and Ca2+ transient plots. Events between the peak and 90 % recovery of Ca2+ transient were included in LCS analysis, and later events classed as diastolic and analysed separately (indicated by * in panels A&D). E & F Probability distribution of where LCS occurred in current clamped cells in relation to E Vm and F as a % of AP repolarization, constructed from Ca2+ sparks detected in n/N = 16/ WT and n/N = 9/2 R420Q cells/hearts. (B–C) n/N (cells/hearts) = 9/3 WT and 9/4 R420Q. Mann-Whitney test.

In AP clamp experiments, some Ca2+ sparks occurred after Vm and [Ca2+] had returned nearly to resting levels and therefore would not normally contribute to APD lengthening but might contribute to DADs (asterisks in Fig. 6A). We performed temporal analysis of LCS in current clamped myocytes, which preserves the normal Ca2+ and voltage feedback mechanism (Fig. 6D). To increase the number of LCS for analysis the first beat after a 5 s pause in 1 Hz pacing with ISO was analysed. Most Ca2+ sparks occurred in R420Q cells between around −45 and − 30 mV, corresponding to approximately 55–70 % AP repolarization, whereas in WT cells a smaller proportion of Ca2+ sparks occurred around −40 mV, with most occurring nearer the resting membrane potential (WT, −74.3 ± 0.8 mV; R420Q, −74.5 ± 0.7 mV; P = 0.80) and after repolarization was complete (Fig. 6E,F). LCS also occurred during the AP in R420Q cells at 35 °C, albeit with more difficultly detecting LCS due to the much faster Ca2+ cycling at this temperature (Fig. S5E).

3.6. Reduced refractoriness and increased sensitivity of RyR2 promote LCS

The increased LCS frequency in R420Q cells might be explained by a change in the refractory period for Ca2+ sparks. It is known that Ca2+ release sites can fire more than once during the Ca2+ transient decay. [32] This can result in multiple LCS at release sites, each separated by a refractory period, that is (at least partly) due to the delay in junctional SR refilling. [32,38] Fig. 7A shows exemplar recordings from WT and R420Q myocytes where an initial LCS was followed by a second LCS ~70 ms later (top and middle panels). Fig. 7B shows that the probability density distribution for the interval between LCS was skewed towards shorter intervals, with the median inter-LCS interval reduced from 172 ms in WT cells to 99 ms in R420Q cells (P = 0.006; Mann Whitney unpaired t-test). The bottom panel of Fig. 7A shows the intensity profile through the centre of each LCS pair. In WT cells the amplitude of the second LCS recovered with a time constant of 90 ms (Fig. 7C), whereas the recovery in R420Q cells was ~2× faster (Fig. 7D). Such an effect would not only increase the frequency of LCS in R420Q but also their individual contribution to the slowing of the Ca2+ transient decay.

Fig. 7. Reduced Ca2+ release refractoriness increases LCS probability in R420Q mouse ventricular myocytes.

Fig. 7

A Exemplar line scan recordings showing pairs of LCS occurring from the same location ~70 ms apart. Middle panels show high-pass filtered recordings. Lower panels show the mean fluorescence through the centre of LCS. B Probability density of intervals between LCS pairs. Dashed lines show the median inter-LCS interval for WT (172 ms) and R420Q cells (99 ms). C Recovery of the second LCS (LCS2) relative to the first (LCS1) was slower in WT compared to D R420Q cells. (C,D) Data points represent one pair of LCS. Shaded areas indicate 95 % prediction interval. Solid lines show a single exponential fit to the data. (B,C,D) 53 LCS pairs from 6/2 WT cells/hearts and 94 LCS pairs from 3/3 R420Q myocytes/hearts.

Most RyR2 mutations associated with CPVT are gain-of-function, [4] however some mutations have atypical phenotypes. [39] Diastolic Ca2+ spark frequency was greater in R420Q myocytes (Fig. S10) confirming that R420Q is a gain-of-function CPVT mutation. We next investigated whether our observations might extend to RyR2 hyperactivity more generally by using an in vitro model of CPVT (low-dose caffeine plus isoproterenol). [40] Fig. S11 shows exemplar confocal Ca2+ line scan recordings of WT cells in the presence of 1 μmol/L ISO and ISO + 1 mmol/L caffeine. [41] LCS frequency was greatly increased and the Ca2+ transient duration was prolonged in the presence of caffeine (Fig. S11C, D). Furthermore, premature electrical stimulation did not elicit arrhythmias in WT hearts in the presence of 100 nmol/L ISO alone (Fig. 3E), but arrhythmias did occur when caffeine was administered in combination with ISO (Fig. S12).

3.7. Computer simulations of hyperactive RyR2 in CPVT

Finally, we sought to extend our main experimental findings with the R420Q mutation in mouse to predict how RyR2 hyperactivity might behave in a larger species with different ion channel contribution and AP morphology. For this we used an established computer model of a ventricular myocyte with three-dimensional spatially distributed Ca2+ release that reproduces the LCS phenomenon and uses rabbit electrophysiology (see also Fig. S14). [31,42] CPVT RyR2 properties were simulated by increasing RyR2 Ca2+ sensitivity ~2× and reducing RyR2 refractoriness (see Supplementary Materials). The simulated Ca2+ line scans in Fig. 8A show that many more LCS occurred in CPVT simulations compared to normal RyR2 properties in the presence of ISO, and this was dependent on RyR2 sensitivity and refractoriness (Fig. 8B). The LCS rate with normal RyR2 was 8.9 LCS/s/100 μm and with CPVT RyR2 was 43.9 LCS/s/100 μm. Notably, this ~5× difference in LCS rate in simulations was close to the ~5× difference in LCS frequency between WT (23.6 LCS/s/100 μm) and R420Q myocytes (117.3 LCS/s/100 μm) measured experimentally during ISO stimulation (c.f. Fig. 5G). CPVT RyR2 reduced the Ca2+ transient amplitude but increased its duration and prolonged the AP (Fig. 8C). Steady state SR load decreased by ~30 % from 896 to 636 μmol/L in CPVT, similar to the ~30 % decrease in SR load measured in TYR and ISO experimentally (Fig. S8).

Fig. 8. Hyperactive RyR2 induces CPVT-like aberrant Ca2+ dynamics in a computer model of spatially distributed Ca2+ release with rabbit electrophysiology.

Fig. 8

[42] A Simulated Ca2+ line scans with normal (Control) and hyperactive CPVT RyR2 properties B (increased Ca2+ sensitivity and reduced refractoriness). B Heatmap showing interaction between RyR2 Ca2+ sensitivity and refractoriness on LCS frequency. White and black asterisks indicate values used for Control and CPVT RyR2 simulations, respectively. C Ca2+ transient amplitude was decreased and the Ca2+ transient and AP duration was increased in CPVT (red lines) compared to Control (black lines). Inward INCX and late ICa were increased during repolarization in CPVT. D & E Amplitude recovery of pairs of LCS during simulated voltage clamp at −40 mV. F Probability density of intervals between LCS pairs, with the median interval in Control (167 ms) and CPVT (89 ms) indicated. G (upper panel) Control and CPVT simulations were paced to steady state at 1 Hz then SR Ca2+ release was blocked at the time indicated. (lower panel) Expanded time view of the final AP during RyR2 block (dashed lines). Also see Fig. S13. H A pace-pause protocol induced EADs in CPVT but not in Control simulations. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

At 50 % AP repolarization, corresponding to −18 mV and approximately mid-phase 3 repolarization, INCX was ~4× greater in CPVT (−0.58 pA/pF) compared to control (−0.14 pA/pF). The increased inward current effectively negated the combined outward current from IKs and IKr at the same timepoint (0.50 pA/pF), whereas in Control there was an excess of these outward currents by around 0.33 pA/pF (Fig. 8C). Peak ICa (7.0 pA/pF Control vs 8.0 pA/pF CPVT) and ICa at 50 % repolarization (−0.48 pA/pF Control vs −0.40 pA/pF CPVT) were similar magnitude between simulations, although late ICa persisted for longer in CPVT possibly due to reduced Ca2+-dependent inactivation.

Increased late ICa or INCX could feasibly explain APD lengthening, so we performed further simulations where SR Ca2+ release was blocked midway through AP repolarization. Fig. 8G shows that blocking RyR2 after the initial evoked Ca2+ release almost normalized the prolonged APD in CPVT. This approach dramatically suppressed LCS in CPVT, but had a smaller effect in Control simulations (Fig. S13A). The magnitude and duration of inward INCX was reduced and there was a brief increase in reverse-mode outward INCX at the moment of block due to decreased subsarcolemmal [Ca2+] (Fig. S13B). Imposing the original ICa from a normal CPVT simulation did not fully restore APD when SR Ca2+ release was blocked (Fig. S13B), suggesting INCX was critical in APD lengthening. Finally, a simulated pacing-pause protocol induced EADs in CPVT but not control simulation (Fig. 8D). Thus, hyperactive RyR2 can contribute to increased LCS and inward INCX that could reduce repolarization reserve and enable arrhythmias arising during repolarization in CPVT.

4. Discussion

4.1. Early afterdepolarization involvement in CPVT caused by gain-of-function RyR2-R420Q

The origin of arrhythmias and extrasystoles in CPVT is usually attributed to diastolic Ca2+ waves and DADs with less attention directed towards ventricular repolarization as a potential source. [58] It was proposed that CPVT patients may be susceptible to both DADs and EADs, [11,43] although an EAD arrhythmia mechanism has not been shown in patients. Our preclinical investigation shows that increased Ca2+ leak during systole, caused by hyperactive RyR2, results in AP prolongation and EADs that could contribute towards the inducibility of arrhythmias in CPVT. This does not require SR Ca2+ overload and thus is mechanistically distinct from ‘Ca2+-release deficiency syndrome’ caused by hypoactive RyR2. [39] Nonetheless, the LCS-EAD mechanism is likely to be exacerbated by increased SR load and this could explain pause-induced abnormal repolarization in CPVT (due to an increase in SR filling time) that is separate from the well-established DAD-mediated mechanism.

We found that APD lengthening in R420Q mouse hearts mainly occurred following pauses and during beta-adrenergic activation, but not during steady rhythm (Fig. 2). This would be consistent with clinical findings that QT interval in CPVT patients typically falls within a normal range at rest, [44,45] but that in some cases QT lengthening and augmented U-waves can occur following pauses, [14,24] or when provoked by adrenergic agents. [46,47] Prolonged resting QT intervals or notched T-waves have been reported in some CPVT patients, [11,12,48,49] although this was not the case in our R420Q patients that instead showed pronounced U-waves (Table 1).

More than 200 mutations in RyR2 have been associated with CPVT, [4] so there may be diversity in phenotype or mutation-specific effects, which raises the question of whether our results are unique to the R420Q mutation? Although it is not feasible to confirm whether the LCS-EAD mechanism occurs in all cases, we did find a similar increase in systolic Ca2+ leak following acute RyR2 sensitization in an in vitro model of CPVT and in computer simulations that should mimic the broader phenomenon of RyR2 gain-of-function. Additionally, patterns of abnormal systolic Ca2+ release were reported in the CASQ2-R33Q model of CPVT [50] and in CaMKIIδC overexpressing mice [51] that would be consistent with increased LCS resulting from RyR2 hyperactivity. It is possible that the clinical presentation may not be definitive as to the underlying arrhythmia mechanism and that there is likely to be some overlap between different inherited heart conditions. In connection with this, a knock-in KCNJ2-R67Q mouse model of Andersen-Tawil Syndrome expressing a loss-of-function Kir2.1 channel with catecholamine-induced decrease in IK1 density developed CPVT-like bidirectional and polymorphic ventricular tachycardia that was likely initiated by EADs without QT lengthening, rather than DADs. [23]

4.2. Prolonged repolarization in CPVT mediated by late Ca2+ sparks

The increase in LCS and slowing of Ca2+ transient decay in R420Q cells was especially pronounced during beta-adrenergic stimulation. The concept of “repolarization reserve” refers to the normal redundancy of repolarizing K+ currents, however drugs or disease that decrease outward or increase inward currents can alter this balance resulting in alterations or failure of repolarization. [28,29] It is known that Ca2+ leak during repolarization can drive afterdepolarizations in other disease contexts, such as heart failure and the long QT syndrome type 2. [31,42] Inclusion of the Ca2+ buffer BAPTA in the patch pipette disrupted the normal feedback between intracellular Ca2+ and Vm via INCX and shortened APD and suppressed triggered activity during beta-adrenergic stimulation in WT and R420Q cells. [22] APD shortening is a normal physiological response to beta-adrenergic stimulation and increased heart rate, whereas the lack of APD shortening in R420Q hearts may increase the vulnerability to re-entrant circuits forming due to functional conduction block and extrasystoles originating from regional heterogeneity in repolarization.

Increased RyR2 sensitivity should cause more efficient evoked Ca2+ release and therefore greater SR Ca2+ depletion, [22] that might be expected to decrease LCS frequency, [34] but this will be offset by the shorter coupling interval and faster recovery between LCS. Recovery of Ca2+ spark amplitude is influenced by the rate of junctional SR refilling [38] but occurs on a slightly faster time course due to, at least in part, the steep dependence of RyR2 open probability on dyadic [Ca2+]. [52] Beta-adrenergic stimulation will accelerate SR refilling and thus further enhance the re-triggerability of LCS. [53] Faster Ca2+ cycling at physiological temperatures should also increase the recovery of LCS due to increased SERCA2a activity and indeed LCS were observed during the AP at 35 °C in CPVT myocytes (Fig. S5E). The time course of the Ca2+ transient and AP that we observed using dual Ca2+/Vm optical mapping (Fig. S9) means that it is feasible that LCS could contribute to AP lengthening during normal heart function, and especially with hyperactive RyR2 due to the shorter LCS refractory period shifting more Ca2+ release within the time frame of AP recovery, although this remains to be demonstrated.

4.3. Synchronization of spontaneous Ca2+ release by heart rhythm

A large number of cells must develop DADs or EADs in near unison (~700,000 in ventricular tissue, but possibly fewer in specialised regions such as the His-Purkinje fibre/endocardium junction [54]) to overcome the source-sink mismatch caused by electrotonic coupling, for triggered activity to propagate. [55] Additionally, the membrane input impedance in diastole is lower than during repolarization, so that INCX will become more effective at causing depolarization (altering dV/dt) during the early phase of the AP than during diastole. Therefore, a smaller LCS-mediated INCX (~0.2 pA/pF) can slow or reverse AP repolarization and facilitate ICa and/or INa reactivation during EADs as a source of triggered beats. [31] It is possible that the influence of heart rhythm on Ca2+ cycling and AP duration may also serve to entrain otherwise stochastic LCS across sufficient cells to further increase the probability of ectopic beats.

Premature stimulation triggered EAD-like behaviour in R420Q hearts (Fig. 3D,E) and premature beats were associated with increased U-wave amplitude in R420Q patients (Fig. S4). Premature stimulation can modulate repolarization gradients across the heart and give rise to conduction block that becomes a substrate for reentry, [56] and this may be exacerbated by increased spontaneous Ca2+ release delaying and causing nonuniformities in repolarization. [40] Increased repolarization dispersion could contribute to U-waves, as shown by the formation of TU complexes due to delayed phase 3 repolarization in canine left ventricular wedge preparations during hypokalemia. [18] At the cellular level, premature APs will elicit smaller Ca2+ transients, due to incomplete SR refilling, and less Ca2+-dependent inactivation of ICa causing a net increase in Ca2+ entry and SR load for subsequent beats that will increase the likelihood of both DADs and EADs.

4.4. Interaction with repolarization mechanisms in other species

The principal repolarization mechanisms in mouse ventricle are different from larger species, such as rabbit and human, with greater reliance on Ito and little or no IKr and IKs, whereas IKr and IKs are major determinants of repolarization in humans, especially upon beta-adrenergic activation. The shorter plateau phase of the rodent AP means that a larger or longer Ca2+ transient will increase INCX more than in humans, where the more positive plateau potential will oppose inward INCX. Conversely, reduced Ca2+-dependent inactivation of ICa due to smaller Ca2+ transient amplitude could prolong APD more in humans. [57] We modified the electrophysiology of the 3D ventricular myocyte computer model to produce a more ‘mouse-like’ AP or a human ventricular AP [58] (Fig. S14). Although these are not intended as a complete representation of mouse electrophysiology, they do serve to illustrate how RyR2 hyperactivity might interact with different AP morphologies. CPVT RyR2 properties increased LCS and Ca2+ transient duration, decreased SR load and Ca2+ transient amplitude and increased APD in all simulations regardless of species. The first rabbit CRISPR knock-in model of CPVT with the gain-of-function RYR2-V2475F+/− mutation has recently been generated and preliminary reports in that model indicated prolonged QT interval in homozygous rabbits, and reduced Ca2+ transient amplitude and reduced SR load in left ventricular cardiomyocytes from heterozygous rabbits. [59,60]

4.5. Limitations

We did not inhibit SR Ca2+ release or INCX in R420Q cells because these approaches would perturb Ca2+ load [61] and Ca2+-dependent inactivation of ICa. [62] Currently, mouse is the only mammalian model of human CPVT mutations, so it was necessary to use this species for the present work. The mouse ventricular AP is shorter and more triangular than human, which reflects differences in the relative contribution of membrane currents to AP repolarization. We expect the mechanisms underlying EAD genesis should be similar to human, as our key findings are supported by in silico experiments using a cardiac myocyte computer model that shares closer similarities to human electrophysiology. Use of human iPSC-derived cardiac myocytes might avoid some of these problems, but the immature structure (e.g. lack of t-tubules), Ca2+ handling and electrophysiology could confound examination of altered excitation-contraction coupling. The RyR2 Arg-420 site is a hotspot for different mutations that produce a typical CPVT phenotype, [4] but we cannot exclude the possibility that some effects may be mutationspecific.

5. Conclusion

We show that RyR2 hyperactivity in CPVT caused by the RyR2-R420Q mutation increased Ca2+ leak in mouse ventricular myocytes during systole due to an excess of LCS, resulting in compromised repolarization reserve and susceptibility to EAD-mediated arrhythmias. This adds to a well-established role for DADs in this disease and indeed, DADs are most likely at fault when the initiating beat is late coupled. [6365] Since current treatments do not provide complete protection in all CPVT patients, [66] we suggest that the development of agents to offset loss of repolarization reserve may have some clinical utility.

Supplementary Material

Supplementary data to this article can be found online at https://doi.org/10.1016/j.yjmcc.2025.07.014. Information on the data underpinning this publication, including access details, can be found in the Cardiff University Research Data Repository at https://doi.org/10.17035/cardiff.29661194

Supplementary material

Acknowledgements

We would like to thank Harry Davies, Caitlin Burns, and Georgia Long for assistance during some experiments. Equipment for whole heart recording and temperature control (TBC-2.2) was kindly provided by MappingLab (Oxford, UK). Human samples for genetic studies included in this study were provided by the Biobanco La Fe (B.0000723) and they were processed following standard operating procedures with the appropriate approval of the Ethics and Scientific Committees. Simulations were performed using the Advanced Research Computing at Cardiff (ARCCA) facilities (Cardiff University).

Funding

AB-B was supported by Memorial Nacho Barberá and Fundación Bancaja. YYW was recipient of a China Scholarship Council doctoral fellowship. This research was supported by a British Heart Foundation Senior Basic Science Research Fellowship to SZ (FS/15/30/31494), French National Agency for Research (ANR-19-14–0031CE-01), NIH (2R01HL055438–22) and European council (RISE MILEAGE grant #734931) to AMG, Medical Research Council UK Program Grant to MBC (MR/N002903/1), British Heart Foundation grants (PG/11/115/29287 and FS/18/42/33827) to BL and a British Heart Foundation Intermediate Basic Science Research Fellowship to EDF (FS-IBSRF-21-25,071).

Footnotes

Statement

AI-assisted technology was not used in the preparation of this work.

CRediT authorship contribution statement

Spyros Zissimopoulos: Writing – review & editing, Supervision, Resources, Funding acquisition, Conceptualization. Pavel Kirilenko: Writing – review & editing, Project administration. Aitana Braza-Boïls: Writing – review & editing, Investigation. Esther Zorio: Writing – review & editing, Resources, Investigation, Formal analysis. Yueyi Wang: Writing – review & editing, Investigation. Ana Maria Gomez: Writing – review & editing, Supervision, Resources. Mark B. Cannell: Writing – review & editing, Resources, Methodology. Branko Latinkic: Writing – review & editing, Supervision. Ewan D. Fowler: Writing – review & editing, Writing – original draft, Supervision, Resources, Methodology, Investigation, Funding acquisition, Formal analysis, Conceptualization.

Declaration of competing interest

None.

References

  • [1].Abbas M, Miles C, Behr E. Catecholaminergic polymorphic ventricular tachycardia. Arrhythmia Electrophysiol Rev. 2022;11:e20. doi: 10.15420/aer.2022.09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [2].Pérez-Riera AR, Barbosa-Barros R, de Rezende Barbosa MPC, Daminello-Raimundo R, de Lucca AA, Jr, de Abreu LC. Catecholaminergic polymorphic ventricular tachycardia, an update. Ann Noninvasive Electrocardiol. 2018;23:e12512. doi: 10.1111/anec.12512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [3].Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, DeSimone L, Coltorti F, Bloise R, Keegan R, Cruz Filho FES, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation. 2002;106:69–74. doi: 10.1161/01.cir.0000020013.73106.d8. [DOI] [PubMed] [Google Scholar]
  • [4].Olubando D, Hopton C, Eden J, Caswell R, Lowri Thomas N, Roberts SA, Morris-Rosendahl D, Venetucci L, Newman WG. Classification and correlation of RYR2 missense variants in individuals with catecholaminergic polymorphic ventricular tachycardia reveals phenotypic relationships. J Hum Genet. 2020;65:531–539. doi: 10.1038/s10038-020-0738-6. [DOI] [PubMed] [Google Scholar]
  • [5].Blackwell DJ, Schmeckpeper J, Knollmann BC. Animal models to study cardiac arrhythmias. Circ Res. 2022;130:1926–1964. doi: 10.1161/CIRCRESAHA.122.320258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [6].Wleklinski MJ, Kannankeril PJ, Knollmann BC. Molecular and tissue mechanisms of catecholaminergic polymorphic ventricular tachycardia. J Physiol. 2020;598:2817–2834. doi: 10.1113/JP276757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [7].Steinberg C, Roston TM, van der Werf C, Sanatani S, Chen SRW, Wilde AAM, Krahn AD. RYR2-ryanodinopathies: from calcium overload to calcium deficiency. EP Europace. 2023;25:euad156. doi: 10.1093/europace/euad156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [8].Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, et al. AHA/ACC/HRS guideline for Management of Patients with Ventricular Arrhythmias and the prevention of sudden cardiac death. Circulation. 2017;138(2018):e272–e391. doi: 10.1161/CIR.0000000000000549. [DOI] [PubMed] [Google Scholar]
  • [9].Sumitomo N, Harada K, Nagashima M, Yasuda T, Nakamura Y, Aragaki Y, Saito A, Kurosaki K, Jouo K, Koujiro M, Konishi S, et al. Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart. 2003;89:66–70. doi: 10.1136/heart.89.1.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [10].Cerrone M, Noujaim SF, Tolkacheva EG, Talkachou A, O’Connell R, Berenfeld O, Anumonwo J, Pandit SV, Vikstrom K, Napolitano C, Priori SG, et al. Arrhythmogenic mechanisms in a mouse model of Catecholaminergic polymorphic ventricular tachycardia. Circ Res. 2007;101:1039–1048. doi: 10.1161/CIRCRESAHA.107.148064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [11].Viitasalo M, Oikarinen L, Väänänen H, Kontula K, Toivonen L, Swan H. U-waves and T-wave peak to T-wave end intervals in patients with catecholaminergic polymorphic ventricular tachycardia, effects of beta-blockers. Heart Rhythm. 2008;5:1382–1388. doi: 10.1016/j.hrthm.2008.06.011. [DOI] [PubMed] [Google Scholar]
  • [12].Kauferstein S, Kiehne N, Erkapic D, Schmidt J, Hamm CW, Bratzke H, Pitschner H-F, Kuniss M, Neumann T. A novel mutation in the cardiac ryanodine receptor gene (RyR2) in a patient with an unequivocal LQTS. Int J Cardiol. 2011;146:249–250. doi: 10.1016/j.ijcard.2010.10.062. [DOI] [PubMed] [Google Scholar]
  • [13].Domingo D, Neco P, Fernández-Pons E, Zissimopoulos S, Molina P, Olagüe J, Suárez-Mier MP, Lai FA, Gómez AM, Zorio E. Non-ventricular, clinical, and functional features of the RyR2R420Q mutation causing Catecholaminergic polymorphic ventricular tachycardia. Rev Esp Cardiol. 2015;68:398–407. doi: 10.1016/j.rec.2014.04.023. [DOI] [PubMed] [Google Scholar]
  • [14].Nof E, Belhassen B, Arad M, Bhuiyan ZA, Antzelevitch C, Rosso R, Fogelman R, Luria D, El-Ani D, Mannens MMAM, Viskin S, et al. Postpacing abnormal repolarization in catecholaminergic polymorphic ventricular tachycardia associated with a mutation in the cardiac ryanodine receptor gene. Heart Rhythm. 2011;8:1546–1552. doi: 10.1016/j.hrthm.2011.05.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [15].Viskin S, Zeltser D, Antzelevitch C. When U Say “U waves,” what do u mean? Pacing Clin Electrophysiol. 2004;27:145–147. doi: 10.1111/j.1540-8159.2004.00403.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [16].Lehmann MH, Suzuki F, Fromm BS, Frankovich D, Elko P, Steinman RT, Fresard J, Baga JJ, Taggart RT. T wave “humps” as a potential electrocardiographic marker of the long QT syndrome. J Am Coll Cardiol. 1994;24:746–754. doi: 10.1016/0735-1097(94)90024-8. [DOI] [PubMed] [Google Scholar]
  • [17].Liu G, Iden JB, Kovithavongs K, Gulamhusein R, Duff HJ, Kavanagh KM. In vivo temporal and spatial distribution of depolarization and repolarization and the illusive murine T wave. J Physiol. 2004;555:267–279. doi: 10.1113/jphysiol.2003.054064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [18].Morita H, Zipes DP, Morita ST, Wu J. Mechanism of U wave and polymorphic ventricular tachycardia in a canine tissue model of Andersen-Tawil syndrome. Cardiovasc Res. 2007;75:510–518. doi: 10.1016/j.cardiores.2007.04.028. [DOI] [PubMed] [Google Scholar]
  • [19].Kashimura T, Briston SJ, Trafford AW, Napolitano C, Priori SG, Eisner DA, Venetucci LA. In the RyR2 R4496C mouse model of CPVT, β-adrenergic stimulation induces ca waves by increasing SR ca content and not by decreasing the threshold for ca waves. Circ Res. 2010;107:1483–1489. doi: 10.1161/CIRCRESAHA.110.227744. [DOI] [PubMed] [Google Scholar]
  • [20].Satoh H, Blatter LA, Bers DM. Effects of [Ca2+]i, SR Ca2+ load, and rest on Ca2+ spark frequency in ventricular myocytes. Am J Phys. 1997;272:H657–H668. doi: 10.1152/ajpheart.1997.272.2.H657. [DOI] [PubMed] [Google Scholar]
  • [21].Wang YY, Mesirca P, Marqués-Sulé E, Zahradnikova A, Villejoubert O, D’Ocon P, Ruiz C, Domingo D, Zorio E, Mangoni ME, Benitah J-P, et al. RyR2R420Q catecholaminergic polymorphic ventricular tachycardia mutation induces bradycardia by disturbing the coupled clock pacemaker mechanism. JCI Insight. 2017;2 doi: 10.1172/jci.insight.91872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [22].Yin L, Zahradnikova A, Rizzetto R, Boncompagni S, Rabesahala de Meritens C, Zhang Y, Joanne P, Marqués-Sulé E, Aguilar-Sánchez Y, Fernández-Tenorio M, Villejoubert O, et al. Impaired binding to Junctophilin-2 and Nanostructural alteration in CPVT mutation. Circ Res. 2021;129:e35–e52. doi: 10.1161/CIRCRESAHA.121.319094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [23].Reilly L, Alvarado FJ, Lang D, Abozeid S, Van Ert H, Spellman C, Warden J, Makielski JC, Glukhov AV, Eckhardt LL. Genetic loss of IK1 causes adrenergic-induced phase 3 early Afterdepolariz ations and polymorphic and bidirectional ventricular tachycardia. Circ Arrhythm Electrophysiol. 2020;13:e008638. doi: 10.1161/CIRCEP.120.008638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [24].Domingo D, López-Vilella R, Arnau MÁ, Cano Ó, Fernández-Pons E, Zorio E. A new mutation in the ryanodine receptor 2 gene (RYR2 C2277R) as a cause Catecholaminergic polymorphic ventricular tachycardia. Rev Esp Cardiol. 2015;68:71–73. doi: 10.1016/j.rec.2014.07.022. [DOI] [PubMed] [Google Scholar]
  • [25].Klein MG, Krantz MJ, Fatima N, Watters A, Colon-Sanchez D, Geiger RM, Goldstein RE, Solhjoo S, Mehler PS, Flagg TP, Haigney MC. Methadone blockade of cardiac inward rectifier K+ current augments membrane instability and amplifies U waves on surface ECGs: a translational study. J Am Heart Assoc. 2022;11:e023482. doi: 10.1161/JAHA.121.023482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [26].Nozaki Y, Kato Y, Uike K, Yamamura K, Kikuchi M, Yasuda M, Ohno S, Horie M, Murayama T, Kurebayashi N, Horigome H. Co-phenotype of left ventricular non-compaction cardiomyopathy and atypical Catecholaminergic polymorphic ventricular tachycardia in association with R169Q, a ryanodine receptor type 2 missense mutation. Circ J. 2020;84:226–234. doi: 10.1253/circj.CJ-19-0720. [DOI] [PubMed] [Google Scholar]
  • [27].Dharmawan T, Nakajima T, Ohno S, Iizuka T, Tamura S, Kaneko Y, Horie M, Kurabayashi M. Identification of a novel exon3 deletion of RYR2 in a family with catecholaminergic polymorphic ventricular tachycardia. Ann Noninvasive Electrocardiol. 2019;24:e12623. doi: 10.1111/anec.12623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [28].Lerman BB, Markowitz SM, Cheung JW, Thomas G, Ip JE. Ventricular tachycardia due to triggered activity: role of early and delayed afterdepolarizations. JACC: Clin Electrophysiol. 2024;10:379–401. doi: 10.1016/j.jacep.2023.10.033. [DOI] [PubMed] [Google Scholar]
  • [29].Roden DM. Taking the “Idio” out of “idiosyncratic”: predicting Torsades de pointes. Pacing Clin Electrophysiol. 1998;21:1029–1034. doi: 10.1111/j.1540-8159.1998.tb00148.x. [DOI] [PubMed] [Google Scholar]
  • [30].January CT, Riddle JM. Early afterdepolarizations: mechanism of induction and block. A role for L-type Ca2+ current. Circ Res. 1989;64:977–990. doi: 10.1161/01.res.64.5.977. [DOI] [PubMed] [Google Scholar]
  • [31].Fowler ED, Wang N, Hezzell M, Chanoit G, Hancox JC, Cannell MB. Arrhythmogenic late Ca2+ sparks in failing heart cells and their control by action potential configuration. Proc Natl Acad Sci USA. 2020;117:2687–2692. doi: 10.1073/pnas.1918649117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [32].Fowler ED, Kong CHT, Hancox JC, Cannell MB. Late Ca2+ Sparks and ripples during the systolic Ca2+ transient in heart muscle cells. Circ Res. 2018;122:473–478. doi: 10.1161/CIRCRESAHA.117.312257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [33].Song Z, Ko CY, Nivala M, Weiss JN, Qu Z. Calcium-voltage coupling in the genesis of early and delayed afterdepolarizations in cardiac myocytes. Biophys J. 2015;108:1908–1921. doi: 10.1016/j.bpj.2015.03.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [34].Fowler ED, Wang N, Hezzell MJ, Chanoit G, Hancox JC, Cannell MB. Improved Ca2+ release synchrony following selective modification of Itof and phase 1 repolarization in normal and failing ventricular myocytes. J Mol Cell Cardiol. 2022;172:52–62. doi: 10.1016/j.yjmcc.2022.07.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [35].Song L-S, Sobie E-A, McCulle S, Lederer WJ, Balke CW, Cheng H. Orphaned ryanodine receptors in the failing heart. Proc Natl Acad Sci. 2006;103:4305–4310. doi: 10.1073/pnas.0509324103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [36].Trafford AW, Díaz ME, Eisner DA. A novel, rapid and reversible method to measure ca buffering and time-course of total sarcoplasmic reticulum ca content in cardiac ventricular myocytes. Pflugers Arch. 1999;437:501–503. doi: 10.1007/s004240050808. [DOI] [PubMed] [Google Scholar]
  • [37].Zima AV, Bovo E, Bers DM, Blatter LA. Ca2+ spark-dependent and -independent sarcoplasmic reticulum Ca2+ leak in normal and failing rabbit ventricular myocytes. J Physiol. 2010;588:4743–4757. doi: 10.1113/jphysiol.2010.197913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [38].Sobie EA, Song L-S, Lederer WJ. Local recovery of Ca2+ release in rat ventricular myocytes. J Physiol. 2005;565:441–447. doi: 10.1113/jphysiol.2005.086496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [39].Zhao Y-T, Valdivia CR, Gurrola GB, Powers PP, Willis BC, Moss RL, Jalife J, Valdivia HH. Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine receptor function. Proc Natl Acad Sci USA. 2015;112 doi: 10.1073/pnas.1419795112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [40].Nam G-B, Burashnikov A, Antzelevitch C. Cellular mechanisms underlying the development of catecholaminergic ventricular tachycardia. Circulation. 2005;111:2727–2733. doi: 10.1161/CIRCULATIONAHA.104.479295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [41].Sankaranarayanan R, Li Y, Greensmith DJ, Eisner DA, Venetucci L. Biphasic decay of the ca transient results from increased sarcoplasmic reticulum ca leak. J Physiol. 2016;594:611–623. doi: 10.1113/JP271473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [42].Zhong M, Rees CM, Terentyev D, Choi B-R, Koren G, Karma A. NCX-mediated subcellular Ca2+ dynamics underlying early afterdepolarizations in LQT2 cardiomyocytes. Biophys J. 2018;115:1019–1032. doi: 10.1016/j.bpj.2018.08.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [43].Kujala K, Paavola J, Lahti A, Larsson K, Pekkanen-Mattila M, Viitasalo M, Lahtinen AM, Toivonen L, Kontula K, Swan H, Laine M, et al. Cell model of Catecholaminergic polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations. PLoS One. 2012;7:e44660. doi: 10.1371/journal.pone.0044660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [44].Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation. 1995;91:1512–1519. doi: 10.1161/01.cir.91.5.1512. [DOI] [PubMed] [Google Scholar]
  • [45].Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, Charron P, Corrado D, Dagres N, de Chillou C, Eckardt L, et al. ESC Scientific Document Group, ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: developed by the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) endorsed by the Association for European Paediatric and Congenital Cardiology (AEPC) Eur Heart J. 2022;43(2022):3997–4126. doi: 10.1093/eurheartj/ehac262. [DOI] [PubMed] [Google Scholar]
  • [46].Tanaka Y, Kawabata M, Scheinman MM, Hirao K. Catecholaminergic polymorphic ventricular tachycardia with QT prolongation. Pacing Clin Electrophysiol. 2015;38:1499–1502. doi: 10.1111/pace.12735. [DOI] [PubMed] [Google Scholar]
  • [47].Hasegawa K, Gao J, Ohno S, Ishida K, Miyazaki S, Makiyama T, Horie M, Uzui H, Tada H. Oral adrenergic agents produced ventricular fibrillation and QT prolongation in an elderly patient carrying an RYR2 variant. Int Heart J. 2022;63:398–403. doi: 10.1536/ihj.21-543. [DOI] [PubMed] [Google Scholar]
  • [48].Saito A, Ohno S, Nuruki N, Nomura Y, Horie M, Yoshinaga M. Three cases of catecholaminergic polymorphic ventricular tachycardia with prolonged QT intervals including two cases of compound mutations. J Arrhythm. 2018;34:291–293. doi: 10.1002/joa3.12053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [49].Kuinose K, Toya T, Yamaga M, Nagatomo Y, Adachi T, Ikegami Y. Unveiling catecholaminergic polymorphic ventricular tachycardia: a case of type 2 ryanodine receptor exon 3 deletion mimicking long QT syndrome type 1. Heart Rhythm Case Rep. 2025;11:43–46. doi: 10.1016/j.hrcr.2024.10.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [50].Liu N, Denegri M, Dun W, Boncompagni S, Lodola F, Protasi F, Napolitano C, Boyden PA, Priori SG. Abnormal propagation of calcium waves and ultrastructural remodeling in recessive catecholaminergic polymorphic ventricular tachycardia. Circ Res. 2013;113:142–152. doi: 10.1161/CIRCRESAHA.113.301783. [DOI] [PubMed] [Google Scholar]
  • [51].Guo T, Zhang T, Ginsburg KS, Mishra S, Brown JH, Bers DM. CaMKIIδC slows [ca]i decline in cardiac myocytes by promoting ca Sparks. Biophys J. 2012;102:2461–2470. doi: 10.1016/j.bpj.2012.04.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [52].Cannell MB, Kong CHT, Imtiaz MS, Laver DR. Control of sarcoplasmic reticulum Ca2+ release by stochastic RyR gating within a 3D model of the cardiac dyad and importance of induction decay for CICR termination. Biophys J. 2013;104:2149–2159. doi: 10.1016/j.bpj.2013.03.058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [53].Ramay HR, Liu OZ, Sobie EA. Recovery of cardiac calcium release is controlled by sarcoplasmic reticulum refilling and ryanodine receptor sensitivity. Cardiovasc Res. 2011;91:598–605. doi: 10.1093/cvr/cvr143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [54].Blackwell DJ, Faggioni M, Wleklinski MJ, Gomez-Hurtado N, Venkataraman R, Gibbs CE, Baudenbacher FJ, Gong S, Fishman GI, Boyle PM, Pfeifer K, et al. The Purkinje–myocardial junction is the anatomic origin of ventricular arrhythmia in CPVT. JCI Insight. 2025;7:e151893. doi: 10.1172/jci.insight.151893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [55].Xie Y, Sato D, Garfinkel A, Qu Z, Weiss JN. So little source, So Much Sink: Requirements for Afterdepolarizations to Propagate in Tissue. Biophys J. 2010;99:1408–1415. doi: 10.1016/j.bpj.2010.06.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [56].Laurita KR, Girouard SD, Akar FG, Rosenbaum DS. Modulated dispersion explains changes in arrhythmia vulnerability during premature stimulation of the heart. Circulation. 1998;98:2774–2780. doi: 10.1161/01.cir.98.24.2774. [DOI] [PubMed] [Google Scholar]
  • [57].Trafford AW, Díaz ME, Negretti N, Eisner DA. Enhanced Ca2+ current and decreased Ca2+ efflux restore sarcoplasmic reticulum Ca2+ content after depletion. Circ Res. 1997;81:477–484. doi: 10.1161/01.res.81.4.477. [DOI] [PubMed] [Google Scholar]
  • [58].Grandi E, Pasqualini FS, Bers DM. A novel computational model of the human ventricular action potential and ca transient. J Mol Cell Cardiol. 2010;48:112–121. doi: 10.1016/j.yjmcc.2009.09.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [59].Zheng J, Dooge H, Valdivia H, Alvarado F. Abstract 14182: a missense mutation in ryanodine receptor 2 leads to structural Remodeling of the heart and cardiac arrhythmia in a rabbit model. Circulation. 2022;146:A14182. doi: 10.1161/circ.146.suppl_1.14182. [DOI] [Google Scholar]
  • [60].Gérard GE, Zheng J, Valdivia HH, Alvarado F, Gomez AM, Benitah J-P, Perrier R. BPS2025 - RyR2-V2475F mutation in rabbit alters cardiomyocyte electrophysiology. Biophys J. 2025;124:208a. doi: 10.1016/j.bpj.2024.11.1153. [DOI] [Google Scholar]
  • [61].Ozdemir S, Bito V, Holemans P, Vinet L, Mercadier J-J, Varro A, Sipido KR. Pharmacological inhibition of Na/ca exchange results in increased cellular Ca2+ load attributable to the predominance of forward mode block. Circ Res. 2008;102:1398–1405. doi: 10.1161/CIRCRESAHA.108.173922. [DOI] [PubMed] [Google Scholar]
  • [62].Bögeholz N, Pauls P, Bauer BK, Schulte JS, Dechering DG, Frommeyer G, Kirchhefer U, Goldhaber JI, Müller FU, Eckardt L, Pott C. Suppression of early and late afterdepolarizations by heterozygous knockout of the Na+/Ca2+ exchanger in a murine model. Circ Arrhythm Electrophysiol. 2015;8:1210–1218. doi: 10.1161/CIRCEP.115.002927. [DOI] [PubMed] [Google Scholar]
  • [63].Sy RW, Gollob MH, Klein GJ, Yee R, Skanes AC, Gula LJ, Leong-Sit P, Gow RM, Green MS, Birnie DH, Krahn AD. Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm. 2011;8:864–871. doi: 10.1016/j.hrthm.2011.01.048. [DOI] [PubMed] [Google Scholar]
  • [64].Paavola J, Viitasalo M, Laitinen-Forsblom PJ, Pasternack M, Swan H, Tikkanen I, Toivonen L, Kontula K, Laine M. Mutant ryanodine receptors in catecholaminergic polymorphic ventricular tachycardia generate delayed afterdepolarizations due to increased propensity to Ca2+ waves. Eur Heart J. 2007;28:1135–1142. doi: 10.1093/eurheartj/ehl543. [DOI] [PubMed] [Google Scholar]
  • [65].Blich M, Marai I, Suleiman M, Lorber A, Gepstein L, Boulous M, Khoury A. Electrocardiographic comparison of ventricular premature complexes during exercise test in patients with CPVT and healthy subjects. Pacing Clin Electrophysiol. 2015;38:398–402. doi: 10.1111/pace.12574. [DOI] [PubMed] [Google Scholar]
  • [66].De Ferrari GM, Dusi V, Spazzolini C, Bos JM, Abrams DJ, Berul CI, Crotti L, Davis AM, Eldar M, Kharlap M, Khoury A, et al. Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia. Circulation. 2015;131:2185–2193. doi: 10.1161/CIRCULATIONAHA.115.015731. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary material

RESOURCES